Clinical Trial Update: Imatinib in Patients With Mucosal or Acral/Lentiginous Melanoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating imatinib in mucosal melanoma, acral lentiginous melanoma, and chronically sun-damaged melanomas. The study results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acral Lentiginous Melanoma
• Chronically Sun-damaged Melanoma
• Mucosal Melanoma

Drugs mentioned

• Imatinib (imatinib)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Mucosal Melanoma, Acral/Lentiginous Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2016-12-08